Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Jul 15, 2023; 15(7): 1182-1199
Published online Jul 15, 2023. doi: 10.4251/wjgo.v15.i7.1182
Published online Jul 15, 2023. doi: 10.4251/wjgo.v15.i7.1182
Figure 2 Expression, prognostic value, and enriched function of COL5A2 in gastric cancer from The Cancer Genome Atlas data.
A: Expression of COL5A2 in gastric cancer (GC), normal (n = 45), tumor (n = 446); B: COL5A2 expression in 27 paired normal and tumor tissues; C: Overall survival of GC patients grouped by COL5A2 median cutoff; D: Forest plots depicting the results of multivariate Cox regression analysis. Age and high expression of COL5A2 predicted a low survival rate independently, n = 322. Error bars represent 95% confidence intervals; E: Gene set enrichment analysis illustrating the key pathways enriched in COL5A2 high expression group. aP < 0.05, bP < 0.01.
- Citation: Yuan HM, Pu XF, Wu H, Wu C. ENTPD1-AS1–miR-144-3p-mediated high expression of COL5A2 correlates with poor prognosis and macrophage infiltration in gastric cancer. World J Gastrointest Oncol 2023; 15(7): 1182-1199
- URL: https://www.wjgnet.com/1948-5204/full/v15/i7/1182.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i7.1182